Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (303)
ARTG (234)
Prescription medicine registration (15)

Date

2024 (31)
2023 (161)
2022 (28)
2021 (55)
2020 (48)
2019 (26)
2018 (52)
2017 (35)
2016 (78)
2014 (2)
2013 (9)
2012 (16)
2011 (2)
2010 (9)

Results for "[search-keyword]"

Search

Sponsor content

552 result(s) found, displaying 41 to 50

RIVAROXABAN-DRLA rivaroxaban 15 mg tablet blister pack (290211)

4 January 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-DRLA rivaroxaban 15 mg tablet blister pack.
RIVAROXABAN-RZ rivaroxaban 15 mg tablet blister pack (290210)

4 January 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-RZ rivaroxaban 15 mg tablet blister pack.
RIVAROXABAN-REDDY'S rivaroxaban 15 mg tablet blister pack (290219)

4 January 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-REDDY'S rivaroxaban 15 mg tablet blister pack.
RIVAROXABAN-RZ rivaroxaban 20 mg tablet blister pack (290214)

4 January 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-RZ rivaroxaban 20 mg tablet blister pack.
FONATPLUS 70 mg/70 ug alendronate (as sodium) and colecalciferol 70 mg/70 microgram (2800 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
FONATPLUS 70 mg/140 ug alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ALENDRONATE PLUS D3 70 mg/140 ug APOTEX alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ALENDRONATE PLUS D3 70 mg/70 ug APOTEX alendronate (as sodium) 70 mg and colecalciferol 70 microgram (2800 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ALENDRONATE PLUS D3 SANDOZ 70 mg/140 microgram alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ALENDRONATE PLUS D3 SANDOZ 70 mg/70 microgram alendronate (as sodium) and colecalciferol 70 mg/70 microgram (2800 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.